Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0012505 | endomembrane system | 2 | 1 |
GO:0031201 | SNARE complex | 3 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4HH15
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0016192 | vesicle-mediated transport | 4 | 11 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006906 | vesicle fusion | 6 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0008104 | protein localization | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0016050 | vesicle organization | 5 | 1 |
GO:0022406 | membrane docking | 2 | 1 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0048278 | vesicle docking | 4 | 1 |
GO:0048284 | organelle fusion | 5 | 1 |
GO:0051640 | organelle localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0061024 | membrane organization | 4 | 1 |
GO:0061025 | membrane fusion | 5 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0090174 | organelle membrane fusion | 6 | 1 |
GO:0140056 | organelle localization by membrane tethering | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 1 |
GO:0005484 | SNAP receptor activity | 3 | 2 |
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 2 |
GO:0060090 | molecular adaptor activity | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 170 | 174 | PF00656 | 0.589 |
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.618 |
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.391 |
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.500 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.400 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 62 | 64 | PF00675 | 0.443 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.367 |
CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.425 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.421 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.345 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.349 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.494 |
CLV_PCSK_PC1ET2_1 | 48 | 50 | PF00082 | 0.376 |
CLV_PCSK_PC7_1 | 29 | 35 | PF00082 | 0.503 |
CLV_PCSK_PC7_1 | 44 | 50 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 231 | 235 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.310 |
DOC_MAPK_gen_1 | 84 | 94 | PF00069 | 0.595 |
DOC_MAPK_MEF2A_6 | 229 | 237 | PF00069 | 0.451 |
DOC_PP1_RVXF_1 | 147 | 153 | PF00149 | 0.680 |
DOC_PP1_RVXF_1 | 229 | 235 | PF00149 | 0.488 |
DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.391 |
DOC_WW_Pin1_4 | 143 | 148 | PF00397 | 0.647 |
LIG_14-3-3_CanoR_1 | 115 | 123 | PF00244 | 0.582 |
LIG_14-3-3_CanoR_1 | 138 | 142 | PF00244 | 0.571 |
LIG_14-3-3_CanoR_1 | 33 | 40 | PF00244 | 0.616 |
LIG_14-3-3_CanoR_1 | 49 | 56 | PF00244 | 0.582 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.570 |
LIG_BIR_III_1 | 1 | 5 | PF00653 | 0.491 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.491 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.599 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.560 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.599 |
LIG_LIR_Gen_1 | 155 | 162 | PF02991 | 0.666 |
LIG_LIR_Gen_1 | 180 | 189 | PF02991 | 0.578 |
LIG_LIR_Gen_1 | 68 | 75 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.666 |
LIG_LIR_Nem_3 | 180 | 185 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 68 | 72 | PF02991 | 0.576 |
LIG_SH2_STAP1 | 157 | 161 | PF00017 | 0.664 |
LIG_SUMO_SIM_anti_2 | 194 | 200 | PF11976 | 0.630 |
LIG_SUMO_SIM_par_1 | 239 | 245 | PF11976 | 0.325 |
LIG_TRAF2_1 | 36 | 39 | PF00917 | 0.635 |
LIG_WRC_WIRS_1 | 123 | 128 | PF05994 | 0.561 |
LIG_WRC_WIRS_1 | 66 | 71 | PF05994 | 0.644 |
MOD_CDC14_SPxK_1 | 146 | 149 | PF00782 | 0.639 |
MOD_CDK_SPxK_1 | 143 | 149 | PF00069 | 0.645 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.617 |
MOD_CK2_1 | 201 | 207 | PF00069 | 0.691 |
MOD_CK2_1 | 32 | 38 | PF00069 | 0.691 |
MOD_Cter_Amidation | 82 | 85 | PF01082 | 0.460 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.466 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.411 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.431 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.624 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.621 |
MOD_N-GLC_1 | 201 | 206 | PF02516 | 0.437 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.418 |
MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.464 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.629 |
MOD_NEK2_2 | 122 | 127 | PF00069 | 0.561 |
MOD_PIKK_1 | 211 | 217 | PF00454 | 0.671 |
MOD_PK_1 | 33 | 39 | PF00069 | 0.643 |
MOD_PKA_1 | 28 | 34 | PF00069 | 0.588 |
MOD_PKA_1 | 48 | 54 | PF00069 | 0.487 |
MOD_PKA_2 | 137 | 143 | PF00069 | 0.566 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.585 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.652 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.612 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.487 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.712 |
MOD_Plk_4 | 137 | 143 | PF00069 | 0.667 |
MOD_ProDKin_1 | 143 | 149 | PF00069 | 0.645 |
MOD_SUMO_for_1 | 40 | 43 | PF00179 | 0.630 |
MOD_SUMO_rev_2 | 43 | 50 | PF00179 | 0.670 |
TRG_DiLeu_BaEn_1 | 137 | 142 | PF01217 | 0.663 |
TRG_DiLeu_BaEn_1 | 70 | 75 | PF01217 | 0.618 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.665 |
TRG_ER_diArg_1 | 217 | 219 | PF00400 | 0.727 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.587 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.574 |
TRG_Pf-PMV_PEXEL_1 | 176 | 180 | PF00026 | 0.435 |
TRG_Pf-PMV_PEXEL_1 | 84 | 89 | PF00026 | 0.437 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3V3 | Leptomonas seymouri | 70% | 100% |
A0A0S4IMX4 | Bodo saltans | 35% | 100% |
A0A0S4J7F1 | Bodo saltans | 25% | 85% |
A0A1X0NZD7 | Trypanosomatidae | 43% | 97% |
A0A3Q8IF56 | Leishmania donovani | 88% | 99% |
A0A3R7NXH1 | Trypanosoma rangeli | 42% | 97% |
A4I444 | Leishmania infantum | 88% | 99% |
C9ZKR8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 97% |
E9ADK9 | Leishmania major | 88% | 100% |
E9AM72 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 99% |
O70439 | Mus musculus | 30% | 96% |
O94651 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 95% |
V5BPW1 | Trypanosoma cruzi | 42% | 97% |